Stifel Nicolaus downgraded shares of Curaleaf (OTCMKTS:CURLF – Free Report) from a buy rating to a sell rating in a research report sent to investors on Monday, MarketBeat.com reports. Several other research firms have also issued reports on CURLF. Alliance Global Partners lowered their target price on shares of Curaleaf from $11.00 to $8.00 and […]
ATB Capital initiated coverage on shares of Curaleaf (OTCMKTS:CURLF – Free Report) in a report released on Wednesday, FlyOnTheWall reports. The brokerage issued an outperform rating on the stock. Other research analysts have also issued reports about the stock. Alliance Global Partners decreased their price objective on shares of Curaleaf from $11.00 to $8.00 and […]
ATB Capital started coverage on shares of Curaleaf (OTCMKTS:CURLF – Free Report) in a research note issued to investors on Wednesday, FlyOnTheWall reports. The brokerage issued an outperform rating on the stock. Several other brokerages have also recently commented on CURLF. Wedbush reiterated an outperform rating and issued a $8.50 price target on shares of […]
Curaleaf (OTCMKTS:CURLF – Get Rating) and Jushi (OTCMKTS:JUSHF – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, risk, institutional ownership, profitability and valuation. Profitability This table compares Curaleaf and Jushi’s net margins, return on […]
Curaleaf (OTCMKTS:CURLF – Get Rating) and Exactus (OTCMKTS:EXDI – Get Rating) are both small-cap consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations. Profitability This table compares Curaleaf and Exactus’ net margins, return […]